Chronic infection with cagA-positive Helicobacter pylori is the strongest risk factor for the development of gastric adenocarcinoma. The cagA gene product CagA is injected into gastric epithelial cells and disturbs cellular functions by physically interacting with and deregulating a variety of cellular signaling molecules. RUNX3 is a tumor suppressor in many tissues, and it is frequently inactivated in gastric cancer. In this study, we show that H. pylori infection inactivates the gastric tumor suppressor RUNX3 in a CagA-dependent manner. CagA directly associates with RUNX3 through a specific recognition of the PY motif of RUNX3 by a WW domain of CagA. Deletion of the WW domains of CagA or mutation of the PY motif in RUNX3 abolishes the ability of CagA to induce the ubiquitination and degradation of RUNX3, thereby extinguishing its ability to inhibit the transcriptional activation of RUNX3. Our studies identify RUNX3 as a novel cellular target of H. pylori CagA and also reveal a mechanism by which CagA functions as an oncoprotein by blocking the activity of gastric tumor suppressor RUNX3.
Introduction
Infection with Helicobacter pylori is the strongest risk factor for gastric carcinoma (Peek and Blaser, 2002; Hatakeyama, 2004; Polk and Peek, 2010) . The H. pylori cag pathogenicity island is a strain-specific locus that encodes a type IV secretion system that injects the bacterial virulence factor CagA into host epithelial cells (Hatakeyama, 2004) . Infection by cagA-positive H. pylori strains is associated with an increased risk for gastric cancer compared with infection by cagA-negative strains (Blaser et al., 1995; Parsonnet et al., 1997; Huang et al., 2003) , implying an important role for CagA in H. pylori-associated gastric diseases.
Upon injection into epithelial cells, intracellular CagA targets host proteins which regulate various cellular responses, including actin-cytoskeletal rearrangements, cell scattering and inflammation, all of which are believed to be involved in H. pylori-mediated gastric carcinogenesis (Hatakeyama, 2004; Peek, 2005) . For example, CagA associates with and activates the cytoplasmic protein tyrosine phosphatase SHP-2, resulting in cytoskeletal reorganization, cell elongation and scattering (Higashi et al., 2002a, b) . CagA also interacts with E-cadherin and destabilizes E-cadherin/b-catenin complexes, leading to the activation of b-catenin, and induces intestinal transdifferentiation in gastric epithelial cells (Franco et al., 2005; Murata-Kamiya et al., 2007) . Therefore, H. pylori CagA, through its association with various host proteins, is actively involved in H. pylori-mediated gastric carcinogenesis. Furthermore, transgenic expression of CagA in mice induces hyperplasia in the gastric mucosa and polyps in the glandular stomach, highlighting the oncogenic potential of CagA in gastric cancer (Ohnishi et al., 2008) .
RUNX3 is a transcription factor that regulates lineage-specific gene expression in developmental processes and is involved in the formation of a variety of cancers (Ito, 2004) . RUNX3 is expressed in glandular stomach epithelial cells, and loss of expression of RUNX3 is causally related to the genesis and progression of gastric cancer and correlates with differentiation, metastasis and poor prognosis of gastric cancer (Li et al., 2002; Wei et al., 2005; Sugiura et al., 2008; Hsu et al., 2009) . RUNX3 is frequently inactivated in gastric cancers by hemizygous deletion, hypermethylation of its promoter or protein mislocalization. The inactivation of RUNX3 appears to occur both in the early stages and throughout the progression of gastric cancer (Li et al., 2002; Ito et al., 2005) . RUNX3 elicits its tumor suppressor functions by controlling the expression of many genes involved in the growth, apoptosis and differentiation of gastric epithelial cells (Chi et al., 2005; Yamamura et al., 2006; Yano et al., 2006) , as well as genes involved in angiogenesis and cell junction formation (Peng et al., 2006; Chang et al., 2009) . Although emerging evidence suggests that RUNX3 is a tumor suppressor, the inactivation of which is involved in the initiation and progression of gastric cancer, the trigger for RUNX3 inactivation within gastric cells is largely unknown.
In this study, we demonstrate that the H. pylori virulence factor, CagA, specifically associates with RUNX3 and downregulates its expression in gastric epithelial cells. CagA targets RUNX3 for ubiquitination and proteasome-mediated degradation. The identification of RUNX3 as a novel cellular target of CagA will help in better understanding the role of CagA as an oncogene and RUNX3 as a tumor suppressor in gastric carcinogenesis.
Results and discussion
H. pylori infection downregulates the expression of RUNX3 in a CagA-dependent manner To explore the possibility that H. pylori infection might lead to the inactivation of RUNX3, we first investigated the effect of H. pylori infection on the transcriptional activity of RUNX3. RUNX3 activates the TbRE luciferase reporter, which contains three RUNX binding sites (Hanai et al., 1999) , in the presence of constitutively activated TGF-b type I receptor in AGS cells (Figure 1a) . However, the transcriptional activity of RUNX3 was inhibited by infection with wild-type (WT) H. pylori, but not with its cagA-deficient isogenic mutant (Figure 1a) , indicating that H. pylori downregulates the transcriptional activity of RUNX3 and that CagA is essential for the inhibition.
To further test whether CagA is sufficient to downregulate the transcriptional activity of RUNX3, we examined the effect of CagA on the transcriptional activity of RUNX3 in the same TbRE luciferase reporter assay. Although co-transfection of CagA did not inhibit the basal activity induced by TbRI in AGS cells, it inhibited the transcriptional activity of RUNX3 in a dose-dependent manner (Figure 1b) . A similar inhibitory effect for CagA on RUNX3 was also observed in HEK293T epithelial cells, wherein RUNX3 showed higher transcription activity than in AGS cells, likely because of the higher transfection efficiency in these cells (Supplementary Figure 1) . These data demonstrate that CagA alone is sufficient to inhibit the transcriptional activity of RUNX3.
Interestingly, examining the cellular levels of RUNX3 in H. pylori-infected AGS cells revealed that the expression of RUNX3 was downregulated by the infection in a CagA-dependent manner (Figure 1c ), indicating that CagA is involved in decreasing RUNX3 expression. To further confirm this, we examined the expression of RUNX3 in H. pylori-infected MKN-45 cells, which express endogenous RUNX3. Infection of MKN-45 cells with WT but not cagA-deficient H. pylori also decreased the expression of RUNX3 in MKN-45 cells (Figure 1d ). More importantly, when we investigated the expression of RUNX3 in H. pylori-infected mice, we found that expression of RUNX3 in gastric mucosa was significantly reduced 48 h after infection with WT H. pylori (Figure 1e , left panel) compared with the expression either after infection with cagA-deficient H. pylori ( Figure 1e , right panel) or in uninfected controls (data not shown). This time point precedes the development of gastric inflammation, further supporting a role of direct microbial effects in carcinogenesis. These in vivo data further support the conclusion that H. pylori reduces the expression of RUNX3 in a CagA-dependent manner. This is also supported by the observation that co-expression of CagA with RUNX3 decreased the cellular levels of RUNX3 (Figure 1f ). The decreased expression of RUNX3 was due to the degradation of RUNX3, as treatment of the cells with proteasome inhibitor MG-132 reversed the decreased expression of RUNX3 ( Figure 1f ) and co-expression of CagA or infection with H. pylori did not alter the RUNX3 mRNA levels ( Supplementary Figures 2 and 3 ).
Collectively, these findings demonstrate that H. pylori CagA induces proteolytic degradation of RUNX3.
The RUNX3 PY motif interacts with the CagA WW domain The CagA-dependent degradation of RUNX3 by H. pylori infection prompted us to examine whether CagA might directly target RUNX3. Immunoprecipitation of CagA from transfected HEK293T cells co-immunoprecipitated RUNX3 (Figure 2a ). The interaction between CagA and RUNX3 was further confirmed with the in vitro GST pull-down (Supplementary Figure 4) , indicating a direct interaction between RUNX3 and CagA. Furthermore, when the physical interaction between CagA and the endogenous RUNX3 was investigated in H. pylori-infected RUNX3-expressing MKN-45 gastric cancer cells, RUNX3 co-immunoprecipitated CagA after H. pylori infection (Figure 2b ). These data demonstrate that CagA associates with RUNX3 in vitro and in vivo in response to H. pylori infection.
To define the region of RUNX3 responsible for its interaction with CagA, we performed an in vitro GST pull-down assay using cell lysates containing various deletion mutants of RUNX3 (Figure 2c ). Full-length RUNX3 and two of its C-terminal deletion mutants (deleted to amino acid 325) were able to associate with CagA ( Figure 2c ). Further deletion to amino acid 283 abolished RUNX3's interaction with CagA (Figure 2c ), indicating that the region from amino acids 283-325 of RUNX3 is critical for its interaction with CagA.
Examining the sequence of amino acids 283-325 revealed that this region contains a PPxY sequence (known as the PY motif), which can be recognized by a WW domain within an interacting partner protein (Sudol et al., 1995) . The WW domain is defined by a conserved tryptophan residue and an invariant proline residue placed approximately 20-22 amino-acid residues apart (Sudol et al., 1995) . Interestingly, in examining the sequence of CagA, we identified two WW domainlike sequences within the N-terminal region of CagA (designated as WW1 and WW2, respectively; Figure 2e ). (Hanai et al., 1999; Ito et al., 2005) for 24 h. In each experiment, cells were also co-transfected with Renilla luciferase reporter plasmid as an internal control. Luciferase activity was measured 24 h after the transfected cells were infected with WT or cagA-deficient H. pylori. Results represent the average of three independent experiments ± s.d. H. pylori NCTC11637 strain and its cagA-deficient isogenic mutant were cultured as previously described (Lamb et al., 2009) . H. pylori was added to AGS cells for infection at an MOI of 50-100. (b) CagA is sufficient to inhibit the transcriptional activity of RUNX3. CagA, RUNX3 and TbRI(CA) were co-transfected with the TbRE reporter plasmid into AGS cells as indicated. 48 h after transfection, luciferase activity was measured as per procedure (a). (c) CagA is essential for the reduced expression of RUNX3 in response to H. pylori infection. AGS cells transiently expressing RUNX3 were infected with WT and cagA-deficient H. pylori for 24 h, and levels of RUNX3, CagA and phosphorylated CagA were detected by immunoblotting whole-cell extracts with anti-RUNX3, anti-CagA, anti-phosphotyrosine or anti-tubulin antibodies. Antibodies against CagA, phosphotyrosine and RUNX3 were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Antibodies against tubulin were purchased from Sigma (St Louis, MO, USA). (d) MKN-45 cells were infected with WT and cagA-deficient H. pylori for 48 h, and levels of RUNX3, CagA and phosphorylated CagA were detected as described in (c). (e) RUNX3 expression is decreased within mouse gastric mucosa early after infection with H. pylori NCTC11637CagA-positive strain. Immunohistochemistry for RUNX3 was performed as previously described (Ito et al., 2008) We then explored the possibility that the PY motif of RUNX3 and the WW domains of CagA might be involved in their interaction. We generated various mutants of RUNX3 or CagA by mutation or deletion of the PY motif or the WW domains and examined their interaction. When the first proline (P) of the PPPY sequence was mutated to alanine (A) (designated as RUNX3-P1A) or the PPPY sequence was deleted (designated as RUNX3-DPY), the interaction of CagA with RUNX3 was significantly impaired (Figure 2d ), indicating that the PY motif is critical for the interaction of RUNX3 with CagA. As for the CagA WW domain deletion mutants, deletion of WW1 of CagA barely affected its interaction with RUNX3 (Figure 2e ). However, deletion of WW2 domain alone or together with WW1 completely abolished its interaction with RUNX3, confirming that the interaction between RUNX3 and CagA is through the specific recognition of the PY motif by the WW domain. motif by the WW domain of CagA was required for the downregulation of the transcriptional activity of RUNX3. When the effect of CagA on the activity of RUNX3 WT or PY motif mutants was examined, we found that RUNX3-P1A and RUNX3-DPY showed resistance to CagA-induced inhibition (Figure 3a) . Furthermore, when the capabilities of the CagA WW domain deletion mutants to down-regulate RUNX3 were tested in the TbRE reporter assay, CagA with the deletion of WW1, WW2 or both barely inhibited the activity of RUNX3 (Figure 3b ). These results demonstrate that the interaction with CagA is critical for the inactivation of the transcriptional activity of RUNX3. Further, we determined whether the interaction between RUNX3 and CagA is essential for the degradation of RUNX3. We first compared the effect of WT CagA on the stability of RUNX3 by measuring the half-life of WT RUNX3 or its PY motif mutants. Consistent with the notion that CagA promotes the degradation of RUNX3, the half-life of RUNX3 was reduced from >4 h to B1.5 h when CagA was co-expressed with RUNX3 (Figure 3c ). Conversely, RUNX3 PY motif mutants were more resistant to CagA-induced degradation, with much longer half-lives (>3 h for RUNX3-P1A and >4 h for RUNX3-DPY) (Figure 3c ), indicating that the PY motif is important for the CagA-induced degradation of RUNX3.
In addition, when the half-life of RUNX3 was measured with CagA WW domain deletion mutants, we found that the half-life of RUNX3 was moderately reduced when cotransfected with either WW1 or WW2 deletion mutants (Figure 3d) . CagA with the deletion of both WW1 and WW2 domains failed to affect the half-life of RUNX3 (Figure 3d ). Collectively, these data support the idea that CagA reduces the stability of RUNX3 through the specific recognition of the PY motif by the WW domain of CagA.
CagA stimulates the ubiquitination of RUNX3 in vivo As CagA stimulates the degradation of RUNX3 (Figure 1 ), we next investigated whether CagA promoted the ubiquitination of RUNX3, an event that is Ubiquitination of RUNX3 was detected as described in (a). (e) Schematic model for the role of CagA in H. pylori infection-induced degradation of RUNX3. After injection into cells, CagA associates with the PY motif of RUNX3 via its WW2 domain. Binding of CagA to RUNX3 recruits an unidentified E3 ligase (E3 X) and initiates the ubiquitination and proteasome-mediated degradation of RUNX3, resulting in the inactivation of its tumor suppressor activity in gastric epithelial cells.
